The Regulatory Science team helps move discoveries from research to commercialization through educational programs, self-service tools, and direct consultation. In partnership with the world-class D.K. Kim International Center for Regulatory Science, the team works closely with investigators to overcome regulatory hurdles on the path to bringing new products to market. Areas of assistance include regulatory agency meeting requests and briefing packages, filings for investigational new drugs (INDs) and investigational device exemptions (IDEs), and general regulatory intelligence, knowledge, and strategy.